Arkolith/Insider Trading/AXLA/Form 4

Epstein David R

DirectorAxcella Health Inc. (AXLA) · full profile →Form 4 · filed Mar 21, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 18, 2022Option exercise(M)2K——163K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 18, 2022Option exercise(M)2K—$00
Mar 17, 2022Grant(A)50K—$050K

Transaction Codes

M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-22-036134) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML